Enricnk
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- $29M
Investors
- 8
About Enricnk
, Ltd. develops CAR-NK and CAR-T cell therapies to treat autoimmune, inflammatory, fibrotic, and genetic diseases through precision immunomodulation and advanced biologic platforms.
Who invested in Enricnk
8 investors across 2 rounds
See all investors in Enricnk
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Enricnk
Who invested in Enricnk?
Enricnk has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enricnk raised?
Enricnk has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Enricnk last raise money?
Enricnk's most recent round on record is a Series A, in Sep 2025.
What does Enricnk do?
Enricnk is a biotechnology company.
Where is Enricnk headquartered?
Enricnk is headquartered in Nanjing, China.
Which VCs invest in companies like Enricnk?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Enricnk's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Enricnk? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.